Standardized uptake value in high uptake area on positron emission tomography with 18F-FRP170 as a hypoxic cell tracer correlates with intratumoral oxygen pressure in glioblastoma

Molecular Imaging and Biology

Volumn 16, Issue 1, 2014, Pages 127-135

  Beppu, Takaaki ^a   Terasaki, Kazunori ^a   Sasaki, Toshiaki ^a   Fujiwara, Shunrou ^a   Matsuura, Hideki ^a   Ogasawara, Kuniaki ^a   Sera, Koichiro ^a   Yamada, Noriyuki ^a   Uesugi, Noriyuki ^a   Sugai, Tamotsu ^a   Kudo, Kohsuke ^a   Sasaki, Makoto ^a   Ehara, Shigeru ^a   Iwata, Ren ^b   Takai, Yoshihiro ^c  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

F FRP170; Glioblastoma; HIF1 ; Hypoxia; Oxygen pressure; PET

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CELL HYPOXIA; FEMALE; FLUORODEOXYGLUCOSE F18; GLIOBLASTOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; NITROIMIDAZOLES; OXYGEN; POSITRON-EMISSION TOMOGRAPHY; PRESSURE;

EID: 84895077148     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-013-0670-7     Document Type: Article

References (31)

1. Jensen RL (2009) Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 92:317-335
2. Jensen RL (2006) Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures. Neurosurg Focus 20:E24
3. Rich JN (2007) Cancer stem cells in radiation resistance. Cancer Res 67:8980-8984
4. Mendichovszky I, Jackson A (2011) Imaging hypoxia in gliomas. Br J Radiol 84(2):S145-S158
5. Eschmann SM, Paulsen F, Reimold M et al (2005) Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 46:253-260
6. Kawai N, Maeda Y, Kudomi N et al (2011) Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma. Eur J Nucl Med Mol Imaging 38:441-450
7. Swanson KR, Chakraborty G, Wang CH et al (2009) Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas. J Nucl Med 50:36-44
8. 18F-FAZA). Eur J Nucl Med Mol Imaging 36:1565-1573
9. Sheehan JP, Popp B, Monteith S et al (2011) Trans sodium crocetinate: functional neuroimaging studies in a hypoxic brain tumor. J Neurosurg 115:749-753
10. 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1alpha expression in patients with glioma. AJNR Am J Neuroradiol 34:92-99
11. Kaneta T, Takai Y, Kagaya Y et al (2002) Imaging of ischemic but viable myocardium using a new 18F-labeled 2-nitroimidazole analog, 18F-FRP170. J Nucl Med 43:109-116
12. 18F]FRP-170 by on-column hydrolysis. Appl Radiat Isot 62:705-710
13. 18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog. J Neurosurg 113:358-368
14. 18F]Fluoromisonidazole positron emission tomography. Int J Oncol 30:873-881
15. Sorensen M, Horsman MR, Cumming P et al (2005) Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors. Int J Radiat Oncol Biol Phys 62:854-861
16. Mahy P, De Bast M, Gallez B et al (2003) In vivo colocalization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors. Radiother Oncol 67:53-61
17. 18F-FAZA PET tracer: a comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry. Radiother Oncol 105:29-35
18. Wang GL, Semenza GL (1995) Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270:1230-1237
19. Collingridge DR, Piepmeier JM, Rockwell S, Knisely JP (1999) Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother Oncol 53:127-131
20. Kayama T, Yoshimoto T, Fujimoto S, Sakurai Y (1991) Intratumoral oxygen pressure in malignant brain tumor. J Neurosurg 74:55-59
21. 18F-FRP170 as a new PET tracer for imaging hypoxia. Ann Nucl Med 21:101-107
22. Chapman JD (1979) Hypoxic sensitizers - implications for radiation therapy. N Engl J Med 301:1429-1432
23. Krohn KA, Link JM, Mason RP (2008) Molecular imaging of hypoxia. J Nucl Med 49(Suppl 2):129S-148S
24. Beppu T, Kamada K, Yoshida Y et al (2002) Change of oxygen pressure in glioblastoma tissue under various conditions. J Neurooncol 58:47-52
25. Brown JM (1979) Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 52:650-656
26. Pistollato F, Abbadi S, Rampazzo E et al (2010) Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Stem Cells 28:851-862
27. Fischer I, Gagner JP, Law M, Newcomb EW, Zagzag D (2005) Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol 15:297-310
28. 18F]FAZA-first small animal PET results. J Pharm Pharm Sic 10:203-211
29. Rampling R, Cruickshank G, Lewis AD et al (1994) Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. Int J Radiat Oncol Biol Phys 29:427-431
30. Piert M, Machulla H, Becker G et al (1999) Introducing fluorine-18 fluoromisonidazole positron emission tomography for the localisation and quantification of pig liver hypoxia. Eur J Nucl Med 26:95-109
31. 18F- fluoromisonidazole small-animal PET data in rats. J Nucl Med 53:1608-1615